Finance

Lists
Outlook: 38.9% bullish·0.0% bearish
Go to analysis
INM:NASDAQ
Mentari Therapeutics, Inc.
$15.56
0.00%
(0.00) 1D
Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INM...
Mkt. cap
969.14M
Avg. vol.
7.77K
Volume
0.00
52-wk high
$23.30
52-wk low
$5.75
EPS
-$2.73
Beta
0.94
Shares outstanding
549.00K
No. of employees
6
Mkt. cap
969.14M
Avg. vol.
7.77K
Volume
0.00
52-wk high
$23.30
52-wk low
$5.75
EPS
-$2.73
Beta
0.94
Shares outstanding
549.00K
No. of employees
6
News stories
From web sources and news partners
About Mentari Therapeutics, Inc.
CEOEric A. Adams
Employees6
Founded1981
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websiteinmedpharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Initiated
$30.00
+92.8%
11/10/2026
Andrew Tsai
Jefferies
Buy
Initiated
$30.00
+92.8%
11/10/2026
Unknown Analyst
Guggenheim
Buy
Initiated
$42.00
+169.9%
11/09/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
820.19K
-
-
-
Cost of goods sold
635.99K
-
-
-
Cost of revenue
635.99K
-
-
-
Research and development expenses
630.64K
1.02M
805.74K
206.02K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.62M
1.74M
2.36M
1.80M
Operating expense
2.30M
2.82M
3.21M
2.01M
Total operating expenses
2.94M
2.82M
3.21M
2.01M
Operating income
-2.12M
-2.82M
-3.21M
-2.01M
Other non operating income
-
-
-
-
EBT including unusual items
-2.03M
-2.79M
-4.84M
-2.00M
EBT excluding unusual items
-2.03M
-2.79M
-3.19M
-2.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.03M
-2.97M
-5.84M
-2.33M
Net profit margin
-247.29%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
74.38K
47.77K
29.06K
14.31K
Interest expense
-
-
-10.70K
-
Net interest expenses
74.38K
47.77K
18.36K
14.31K
Depreciation and amortization charges
53.20K
51.71K
48.36K
168.00
EBITDA
-2.07M
-2.77M
-3.16M
-2.01M
Gain or loss from assets sale
-
-
7.14K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps